Contribution of Particle Design Research to the Development of Patient-Centric Dosage Forms
Source abstract
Abstract
A variety of dosage forms have been developed in order to achieve effective and safe drug delivery in topical or systemic drug administrations. In this review, formulation research and process issues related to a popular oral dosage form, the tablet, are introduced. Research on oral dosage forms, including orally disintegrating tablets (ODTs) and films (ODFs), which have recently been developed with an aim toward more patient-centric drug therapy, is also introduced. Another trend in recent drug therapy is an increase in the number of large bioactive molecules among the newly developed active pharmaceutical ingredients (APIs). To design dosage forms for these APIs, novel dosage form design and administration routes are required. For this purpose, we have tried to effectively use the polymer-coated liposomes in oral, pulmonary and ophthalmic administration. For example, suitable polymers were introduced for the design of specific administration routes, such as mucoadhesive liposomes for oral administration. The key point in these researches is the particle design for the component particles of final dosage forms, both in the case of coarse powder particle design for formulating solid dosage forms and in the case of colloidal particle design, such as the design of liposomes for peptide drug delivery.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Drug Solubulity and Delivery Systems · Advanced Drug Delivery Systems · Pharmaceutical studies and practices
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Laboratory of Advanced Pharmaceutical Process Engineering, Gifu Pharmaceutical University, Japan
References (100+)
Show source-provided references
1. Allen T.M., Hansen C., Martin F., Redemann C., Yau-Young A., Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo, Biochimica et Biophysica Acta (BBA)—Biomembranes, 1066 (1991) 29–36. DOI: 10.1016/0005-2736(91)90246-510.1016/0005-2736(91)90246-5 ↗
2. Allen T.M., Hansen C., Rutledge J., Liposomes with prolonged circulation times: factors affecting uptake by reticuloendothelial and other tissues, Biochimica et Biophysica Acta (BBA)—Biomembranes, 981 (1989) 27–35. DOI: 10.1016/0005-2736(89)90078-310.1016/0005-2736(89)90078-3 ↗
3. Amidon G.L., Lennernäs H., Shah V.P., Crison J.R., A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability, Pharmaceutical Research, 12 (1995) 413–420. DOI: 10.1023/A:101621280428810.1023/A:1016212804288 ↗
4. Buckton G., Darcy P., Water mobility in amorphous lactose below and close to the glass transition temperature, International Journal of Pharmaceutics, 136 (1996) 141–146. DOI: 10.1016/0378-5173(96)04503-610.1016/0378-5173(96)04503-6 ↗
5. Carless J.E., Leigh S., Compression characteristics of powders: radial die wall pressure transmission and density changes, Journal of Pharmacy and Pharmacology, 26 (1974) 289–297. DOI: 10.1111/j.2042-7158.1974.tb09278.x10.1111/j.2042-7158.1974.tb09278.x ↗
6. Chiou W.L., Riegelman S., Preparation and dissolution characteristics of several fast-release solid dispersions of griseofulvin, Journal of Pharmaceutical Sciences, 58 (1969) 1505–1510. DOI: 10.1002/jps.260058121810.1002/jps.2600581218 ↗
7. Corrigan O.I., Holohan E.M., Sabra K., Amorphous forms of thiazide diuretics prepared by spray-drying, International Journal of Pharmaceutics, 18 (1984) 195–200. DOI: 10.1016/0378-5173(84)90119-410.1016/0378-5173(84)90119-4 ↗
8. Corrigan O.I., Sabra K., Holohan E.M., Physicochemical properties of spray dried drugs: phenobarbitone and hydroflumethiazide, Drug Development and Industrial Pharmacy, 9 (1983) 1–20. DOI: 10.3109/0363904830904854110.3109/03639048309048541 ↗
9. Couvreur P., Kante B., Roland M., Guiot P., Bauduin P., Speiser P., Polycyanoacrylate nanocapsules as potential lysosomotropic carriers: preparation, morphological and sorptive properties, Journal of Pharmacy and Pharmacology, 31 (1979) 331–332. DOI: 10.1111/j.2042-7158.1979.tb13510.x10.1111/j.2042-7158.1979.tb13510.x ↗
10. Danjo K., Kamiya K., Otsuka A., Effect of temperature on the sticking of low melting point materials, Chemical & Pharmaceutical Bulletin, 41 (1993) 1423–1427. DOI: 10.1248/cpb.41.142310.1248/cpb.41.1423 ↗
11. Danjo K., Kojima S., Chen C.Y., Sunada H., Otsuka A., Effect of water content on sticking during compression, Chemical & Pharmaceutical Bulletin, 45 (1997) 706–709. DOI: 10.1248/cpb.45.70610.1248/cpb.45.706 ↗
12. Dapergolas G., Gregoriadis G., Hypoglycæmic effect of liposome-entrapped insulin administered intragastrically into rats, The Lancet, 308 (1976) 824–827. DOI: 10.1016/S0140-6736(76)91209-510.1016/S0140-6736(76)91209-5 ↗
13. Ford J.L., The current status of solid dispersions, Pharmaceutica Acta Helvetiae, 61 (1986) 69–88. https://pubmed.ncbi.nlm.nih.gov/3520598/
14. Fujisawa T., Miyai H., Hironaka K., Tsukamoto T., Tahara K., Tozuka Y., Ito M., Takeuchi H., Liposomal diclofenac eye drop formulations targeting the retina: formulation stability improvement using surface modification of liposomes, International Journal of Pharmaceutics, 436 (2012) 564–567. DOI: 10.1016/j.ijpharm.2012.07.02410.1016/j.ijpharm.2012.07.024 ↗
15. Gupta P.K., Leung S.-H.S., Robinson J.R., Bioadhesives/mucoadhesives in drug delivery to the gastrointestinal tract, in: Vincent Lenaerts, Gurny Robert (Eds.) Bioadhesive Drug Delivery Systems, CRC Press, Florida, 1990, pp. 65–92, ISBN 9780849353673.
16. Hiestand E.N., Wells J.E., Peot C.B., Ochs J.F., Physical processes of tableting, Journal of Pharmaceutical Sciences, 66 (1977) 510–519. DOI: 10.1002/jps.260066041310.1002/jps.2600660413 ↗
17. Hironaka K., Inokuchi Y., Fujisawa T., Shimazaki H., Akane M., Tozuka Y., Tsuruma K., Shimazawa M., Hara H., Takeuchi H., Edaravone-loaded liposomes for retinal protection against oxidative stress-induced retinal damage, European Journal of Pharmaceutics and Biopharmaceutics, 79 (2011) 119–125. DOI: 10.1016/j.ejpb.2011.01.01910.1016/j.ejpb.2011.01.019 ↗
18. Hironaka K., Inokuchi Y., Tozuka Y., Shimazawa M., Hara H., Takeuchi H., Design and evaluation of a liposomal delivery system targeting the posterior segment of the eye, Journal of Controlled Release, 136 (2009) 247–253. DOI: 10.1016/j.jconrel.2009.02.02010.1016/j.jconrel.2009.02.020 ↗
19. Humbert-Droz P., Gurny R., Mordier D., Doelker E., Densification behaviour of drugs presenting availability problems, International Journal of Pharmaceutical Technology and Product Manufacture, 4 (1983) 29–35.
20. Inokuchi Y., Hironaka K., Fujisawa T., Tozuka Y., Tsuruma K., Shimazawa M., Takeuchi H., Hara H., Physicochemical properties affecting retinal drug/coumarin-6 delivery from nanocarrier systems via eyedrop administration, Investigative Ophthalmology & Visual Science, 51 (2010) 3162–3170. DOI: 10.1167/iovs.09-469710.1167/iovs.09-4697 ↗
21. Johnson L.M., Mecham J.B., Quinn F., Hickey A.J., Nanoparticle technology for respiratory tract mucosal vaccine delivery, KONA Powder and Particle Journal, 37 (2020) 97–113. DOI: 10.14356/kona.202001310.14356/kona.2020013 ↗
22. Kakimi K., Niwa T., Danjo K., Influence of compression pressure and velocity on tablet sticking, Chemical and Pharmaceutical Bulletin, 58 (2010) 1565–1568. DOI: 10.1248/cpb.58.156510.1248/cpb.58.1565 ↗
23. Kakino Y., Hishikawa Y., Onodera R., Tahara K., Takeuchi H., Gelation factors of pectin for development of a powder form of gel, dry jelly, as a novel dosage form, Chemical and Pharmaceutical Bulletin, 65 (2017) 1035–1044. DOI: 10.1248/cpb.c17-0044710.1248/cpb.c17-00447 ↗
24. Kawashima Y., Serigano T., Hino T., Yamamoto H., Takeuchi H., A new powder design method to improve inhalation efficiency of pranlukast hydrate dry powder aerosols by surface modification with hydroxypropylmethylcellulose phthalate nanospheres, Pharmaceutical Research, 15 (1998a) 1748–1752. DOI: 10.1023/A:101191693065510.1023/A:1011916930655 ↗
25. Kawashima Y., Serigano T., Hino T., Yamamoto H., Takeuchi H., Design of inhalation dry powder of pranlukast hydrate to improve dispersibility by the surface modification with light anhydrous silicic acid (AEROSIL 200), International Journal of Pharmaceutics, 173 (1998b) 243–251. DOI: 10.1016/S0378-5173(98)00243-910.1016/S0378-5173(98)00243-9 ↗
26. Keck C.M., Müller R.H., Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation, European Journal of Pharmaceutics and Biopharmaceutics, 62 (2006) 3–16. DOI: 10.1016/j.ejpb.2005.05.00910.1016/j.ejpb.2005.05.009 ↗
27. Knight C.G. (Ed.), Liposomes: From Physical Structure to Therapeutic Applications, Elsevier, Amsterdam (1981), ISBN: 9780444803207.
28. Kreuter K. (Ed.), Colloidal Drug Delivery Systems., Marcell Dekker, New York (1994). ISBN: 9780824792145.
29. Kuno Y., Kojima M., Ando S., Nakagami H., Effect of preparation method on properties of orally disintegrating tablets made by phase transition, International Journal of Pharmaceutics, 355 (2008) 87–92. DOI: 10.1016/j.ijpharm.2007.11.04610.1016/j.ijpharm.2007.11.046 ↗
30. Liversidge G.G., Cundy K.C., Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs, International Journal of Pharmaceutics, 125 (1995) 91–97. DOI: 10.1016/0378-5173(95)00122-Y10.1016/0378-5173(95)00122-Y ↗
31. Makhlof A., Fujimoto S., Tozuka Y., Takeuchi H., In vitro and in vivo evaluation of WGA–carbopol modified liposomes as carriers for oral peptide delivery, European Journal of Pharmaceutics and Biopharmaceutics, 77 (2011a) 216–224. DOI: 10.1016/j.ejpb.2010.12.00810.1016/j.ejpb.2010.12.008 ↗
32. Makhlof A., Werle M., Tozuka Y., Takeuchi H., A mucoadhesive nanoparticulate system for the simultaneous delivery of macromolecules and permeation enhancers to the intestinal mucosa, Journal of Controlled Release, 149 (2011b) 81–88. DOI: 10.1016/j.jconrel.2010.02.00110.1016/j.jconrel.2010.02.001 ↗
33. McGinity J.W. (Ed.), Aqueous Polymeric Coatings for Pharmaceutical Dosage Forms, 2nd ed., Marcel Dekker, New York (1997), ISBN: 9780824797737.
34. Merisko-Liversidge E., Liversidge G.G., Cooper E.R., Nanosizing: a formulation approach for poorly-water-soluble compounds, European Journal of Pharmaceutical Sciences, 18 (2003) 113–120. DOI: 10.1016/S0928-0987(02)00251-810.1016/S0928-0987(02)00251-8 ↗
35. Michaut F., Busignies V., Fouquereau C., Huet de Barochez B., Leclerc B., Tchoreloff P., Evaluation of a rotary tablet press simulator as a tool for the characterization of compaction properties of pharmaceutical products, Journal of Pharmaceutical Sciences, 99 (2010) 2874–2885. DOI: 10.1002/jps.2203210.1002/jps.22032 ↗
36. Müller R.H., Peters K., Nanosuspensions for the formulation of poorly soluble drugs: i. preparation by a size-reduction technique, International Journal of Pharmaceutics, 160 (1998) 229–237. DOI: 10.1016/S0378-5173(97)00311-610.1016/S0378-5173(97)00311-6 ↗
37. Murata M., Nakano K., Tahara K., Tozuka Y., Takeuchi H., Pulmonary delivery of elcatonin using surface-modified liposomes to improve systemic absorption: polyvinyl alcohol with a hydrophobic anchor and chitosan oligosaccharide as effective surface modifiers, European Journal of Pharmaceutics and Biopharmaceutics, 80 (2012) 340–346. DOI: 10.1016/j.ejpb.2011.10.01110.1016/j.ejpb.2011.10.011 ↗
38. Murata M., Tahara K., Takeuchi H., Real-time in vivo imaging of surface-modified liposomes to evaluate their behavior after pulmonary administration, European Journal of Pharmaceutics and Biopharmaceutics, 86 (2014) 115–119. DOI: 10.1016/j.ejpb.2013.09.00610.1016/j.ejpb.2013.09.006 ↗
39. Nagai T., Adhesive topical drug delivery system, Journal of Controlled Release, 2 (1985) 121–134. DOI: 10.1016/0168-3659(85)90038-010.1016/0168-3659(85)90038-0 ↗
40. Naito S., Nakamichi K., Studies on techniques of manufacturing pharmacy. i. prediction of tableting troubles such as capping and sticking. (i), Chemical & Pharmaceutical Bulletin, 17 (1969) 2507–2514. DOI: 10.1248/cpb.17.250710.1248/cpb.17.2507 ↗
41. Nakano K., Tozuka Y., Takeuchi H., Effect of surface properties of liposomes coated with a modified polyvinyl alcohol (PVA-R) on the interaction with macrophage cells, International Journal of Pharmaceutics, 354 (2008) 174–179. DOI: 10.1016/j.ijpharm.2007.08.04610.1016/j.ijpharm.2007.08.046 ↗
42. Narang A.S., Rao V.M., Guo H., Lu J., Desai D.S., Effect of force feeder on tablet strength during compression, International Journal of Pharmaceutics, 401 (2010) 7–15. DOI: 10.1016/j.ijpharm.2010.08.02710.1016/j.ijpharm.2010.08.027 ↗
43. Newton J.M., Haririan I., Podczeck F., The influence of punch curvature on the mechanical properties of compacted powders, Powder Technology, 107 (2000) 79–83. DOI: 10.1016/S0032-5910(99)00173-410.1016/S0032-5910(99)00173-4 ↗
44. Okuda Y., Irisawa Y., Okimoto K., Osawa T., Yamashita S., A new formulation for orally disintegrating tablets using a suspension spray-coating method, International Journal of Pharmaceutics, 382 (2009) 80–87. DOI: 10.1016/j.ijpharm.2009.08.01010.1016/j.ijpharm.2009.08.010 ↗
45. Osamura T., Takeuchi Y., Onodera R., Kitamura M., Takahashi Y., Tahara K., Takeuchi H., Characterization of tableting properties measured with a multi-functional compaction instrument for several pharmaceutical excipients and actual tablet formulations, International Journal of Pharmaceutics, 510 (2016) 195–202. DOI: 10.1016/j.ijpharm.2016.05.02410.1016/j.ijpharm.2016.05.024 ↗
46. Osamura T., Takeuchi Y., Onodera R., Kitamura M., Takahashi Y., Tahara K., Takeuchi H., Prediction of effects of punch shapes on tableting failure by using a multi-functional single-punch tablet press, Asian Journal of Pharmaceutical Sciences, 12 (2017) 412–417. DOI: 10.1016/j.ajps.2017.05.00110.1016/j.ajps.2017.05.001 ↗
47. Osamura T., Takeuchi Y., Onodera R., Kitamura M., Takahashi Y., Tahara K., Takeuchi H., Formulation design of granules prepared by wet granulation method using a multi-functional single-punch tablet press to avoid tableting failures, Asian Journal of Pharmaceutical Sciences, 13 (2018) 113–119. DOI: 10.1016/j.ajps.2017.08.00210.1016/j.ajps.2017.08.002 ↗
48. Papahadjopoulos D., Allen T.M., Gabizon A., Mayhew E., Matthay K., Huang S.K., Lee K.D., Woodle M.C., Lasic D.D., Redemann C., Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy, Proceedings of the National Academy of Sciences, 88 (1991) 11460–11464. DOI: 10.1073/pnas.88.24.1146010.1073/pnas.88.24.11460 ↗
49. Patel H.M., Ryman B.E., Oral administration of insulin by encapsulation within liposomes, FEBS Letters, 62 (1976) 60–63. DOI: 10.1016/0014-5793(76)80016-610.1016/0014-5793(76)80016-6 ↗
50. Patel H.M., Ryman B.E., Systemic and oral administration of liposomes, In: C.G. Knight (Ed.), Liposomes: From Physical Structure to Therapeutic Applications, Elsevier, Amsterdam, 1981, pp. 409–441. ISBN: 9780444802347.
51. Picker K.M., Time dependence of elastic recovery for characterization of tableting materials, Pharmaceutical Development and Technology, 6 (2001) 61–70. DOI: 10.1081/PDT-10000001410.1081/PDT-100000014 ↗
52. Pikal M.J., Lukes A.L., Lang J.E., Gaines K., Quantitative crystallinity determinations for β-lactam antibiotics by solution calorimetry: correlations with stability, Journal of Pharmaceutical Sciences, 67 (1978) 767–773. DOI: 10.1002/jps.260067060910.1002/jps.2600670609 ↗
53. Pitt K.G., Webber R.J., Hill K.A., Dey D., Gamlen M.J., Compression prediction accuracy from small scale compaction studies to production presses, Powder Technology, 270 (2015) 490–493. DOI: 10.1016/j.powtec.2013.10.00710.1016/j.powtec.2013.10.007 ↗
54. Ponchel G., Montisci M.-J., Dembri A., Durrer C., Duchêne D., Mucoadhesion of colloidal particulate systems in the gastro-intestinal tract, European Journal of Pharmaceutics and Biopharmaceutics, 44 (1997) 25–31. DOI: 10.1016/S0939-6411(97)00098-210.1016/S0939-6411(97)00098-2 ↗
55. Price D.N., Kunda N.K., Muttil P., Challenges associated with the pulmonary delivery of therapeutic dry powders for preclinical testing, KONA Powder and Particle Journal, 36 (2019) 129–144. DOI: 10.14356/kona.201900810.14356/kona.2019008 ↗
56. Roberts M., Ford J.L., Rowe P.H., Dyas A.M., MacLeod G.S., Fell J.T., Smith G.W., Effect of lubricant type and concentration on the punch tip adherence of model ibuprofen formulations, Journal of Pharmacy and Pharmacology, 56 (2004) 299–305. DOI: 10.1211/002235702282710.1211/0022357022827 ↗
57. Saleki-Gerhardt A., Zografi G., Non-isothermal and isothermal crystallization of sucrose from the amorphous state, Pharmaceutical Research, 11 (1994) 1166–1173. DOI: 10.1023/A:101894511747110.1023/A:1018945117471 ↗
58. Sasaki H., Karasawa K., Hironaka K., Tahara K., Tozuka Y., Takeuchi H., Retinal drug delivery using eyedrop preparations of poly-l-lysine-modified liposomes, European Journal of Pharmaceutics and Biopharmaceutics, 83 (2013) 364–369. DOI: 10.1016/j.ejpb.2012.10.01410.1016/j.ejpb.2012.10.014 ↗
59. Seager H., Drug-delivery products and the Zydis fast-dissolving dosage form, Journal of Pharmacy and Pharmacology, 50 (2011) 375–382. DOI: 10.1111/j.2042-7158.1998.tb06876.x10.1111/j.2042-7158.1998.tb06876.x ↗
60. Sebhatu T., Ahlneck C., Alderborn G., The effect of moisture content on the compression and bond-formation properties of amorphous lactose particles, International Journal of Pharmaceutics, 146 (1997) 101–114. DOI: 10.1016/S0378-5173(96)04777-110.1016/S0378-5173(96)04777-1 ↗
61. Sebhatu T., Elamin A.A., Ahlneck C., Effect of moisture sorption on tabletting characteristics of spray dried (15 % amorphous) lactose, Pharmaceutical Research, 11 (1994) 1233–1238. DOI: 10.1023/A:101897392383110.1023/A:1018973923831 ↗
62. Sekiguchi K., Obi N., Studies on absorption of eutectic mixture. i. a comparison of the behavior of eutectic mixture of sulfathiazole and that of ordinary sulfathiazole in man, Chemical & Pharmaceutical Bulletin, 9 (1961) 866–872. DOI: 10.1248/cpb.9.86610.1248/cpb.9.866 ↗
63. Senior J.H., Fate and behavior of liposomes in vivo: a review of controlling factors, Critical Reviews in Therapeutic Drug Carrier Systems, 3 (1987) 123–193. PMID: 3542245.
64. Shenfield G.M., Hill J.C., Infrequent response by diabetic rats to insulin-liposomes, Clinical and Experimental Pharmacology and Physiology, 9 (1982) 355–361. DOI: 10.1111/j.1440-1681.1982.tb00819.x10.1111/j.1440-1681.1982.tb00819.x ↗
65. Shimazawa M., Inoue Y., Masuda T., Onodera R., Tahara K., Shimizu Y., Mibe Y., Tsuruma K., Takeuchi H., Hara H., Topical diclofenac-loaded liposomes ameliorate laser-induced choroidal neovascularization in mice and non-human primates, Current Neurovascular Research, 14 (2017) 46–52. DOI: 10.2174/156720261466616110411544010.2174/1567202614666161104115440 ↗
66. Simonelli A.P., Mehta S.C., Higuchi W.I., Dissolution rates of high energy polyvinylpyrrolidone (PVP)-sulfathiazole coprecipitates, Journal of Pharmaceutical Sciences, 58 (1969) 538–549. DOI: 10.1002/jps.260058050310.1002/jps.2600580503 ↗
67. Sixsmith D., McCluskey D., The effect of punch tip geometry on powder movement during the tableting process, Journal of Pharmacy and Pharmacology, 33 (1981) 79–81. DOI: 10.1111/j.2042-7158.1981.tb13715.x10.1111/j.2042-7158.1981.tb13715.x ↗
68. Stubberud L., Arwidsson H.G., Hjortsberg V., Graffner C., Water-solid interactions. iii. effect of glass transition temperature, Tg, and processing on tensile strength of compacts of lactose and lactose/polyvinyl pyrrolidone, Pharmaceutical Development and Technology, 1 (1996) 195–204. DOI: 10.3109/1083745960902989410.3109/10837459609029894 ↗
69. Stubberud L., Forbes R.T., The use of gravimetry for the study of the effect of additives on the moisture-induced recrystallisation of amorphous lactose, International Journal of Pharmaceutics, 163 (1998) 145–156. DOI: 10.1016/S0378-5173(97)00382-710.1016/S0378-5173(97)00382-7 ↗
70. Sugihara H., Yamamoto H., Kawashima Y., Takeuchi H., Effectiveness of submicronized chitosan-coated liposomes in oral absorption of indomethacin, Journal of Liposome Research, 22 (2012) 72–79. DOI: 10.3109/08982104.2011.62112810.3109/08982104.2011.621128 ↗
71. Sugimori K., Mori S., Kawashima Y., Characterization of die wall pressure to predict capping of flat- or convex-faced drug tablets of various sizes, Powder Technology, 58 (1989a) 259–264. DOI: 10.1016/0032-5910(89)80052-X10.1016/0032-5910(89)80052-X ↗
72. Sugimori K., Mori S., Kawashima Y., Introduction of new index for the prediction of capping tendency of tablets, Chemical & Pharmaceutical Bulletin, 37 (1989b) 458–462. DOI: 10.1248/cpb.37.45810.1248/cpb.37.458 ↗
73. Sugimoto M., Narisawa S., Matsubara K., Yoshino H., Nakano M., Handa T., Development of manufacturing method for rapidly disintegrating oral tablets using the crystalline transition of amorphous sucrose, International Journal of Pharmaceutics, 320 (2006) 71–78. DOI: 10.1016/j.ijpharm.2006.04.00410.1016/j.ijpharm.2006.04.004 ↗
74. Sun C.C., Dependence of ejection force on tableting speed—A compaction simulation study, Powder Technology, 279 (2015) 123–126. DOI: 10.1016/j.powtec.2015.04.00410.1016/j.powtec.2015.04.004 ↗
75. Tahara K., Nishikawa M., Matsui K., Hisazumi K., Onodera R., Tozuka Y., Takeuchi H., In vitro and in vivo characterization of drug nanoparticles prepared using PureNano™ continuous crystallizer to improve the bioavailability of poorly water soluble drugs, Pharmaceutical Research, 33 (2016) 2259– 2268. DOI: 10.1007/s11095-016-1964-710.1007/s11095-016-1964-7 ↗
76. Takahashi T., Toyota H., Kuroiwa Y., Yoshino H., Kondou H., Yamashita K., Hakomori T., Takeuchi H., Quantitative evaluation of different rotary tablet presses by compaction velocity based on compaction simulation study, International Journal of Pharmaceutics, 558 (2019) 157–164. DOI: 10.1016/j.ijpharm.2018.12.03210.1016/j.ijpharm.2018.12.032 ↗
77. Takahashi T., Toyota H., Kuroiwa Y., Kondo H., Dohi M., Hakomori T., Nakamura M., Takeuchi H., Application of novel compaction indicator for the optimization of compaction conditions based on a compaction simulation study, International Journal of Pharmaceutics, 587 (2020) 119574. DOI: 10.1016/j.ijpharm.2020.11957410.1016/j.ijpharm.2020.119574 ↗
78. Taketani Y., Usui T., Toyono T., Shima N., Yokoo S., Kimakura M., Yamagami S., Ohno S., Onodera R., Tahara K., Takeuchi H., Kuroda M., Topical use of angiopoietin-like protein 2 RNAi-loaded lipid nanoparticles suppresses corneal neovascularization, Molecular Therapy—Nucleic Acids, 5 (2016) e292. DOI: 10.1038/mtna.2016.110.1038/mtna.2016.1 ↗
79. Takeuchi H., Fuji Sylysia Chemical Ltd., Tablet and method for producing the same, Jpn. Patent No. 5026675 (2012).
80. Takeuchi H., Handa T., Kawashima Y., Enhancement of the dissolution rate of a poorly water-soluble drug (tolbutamide) by a spray-drying solvent deposition method and disintegrants, Journal of Pharmacy and Pharmacology, 39 (1987a) 769–773. DOI: 10.1111/j.2042-7158.1987.tb05117.x10.1111/j.2042-7158.1987.tb05117.x ↗
81. Takeuchi H., Handa T., Kawashima Y., Spherical solid dispersion containing amorphous tolbutamide embedded in enteric coating polymers or colloidal silica prepared by spray-drying technique, Chemical & Pharmaceutical Bulletin, 35 (1987b) 3800–3806. DOI: 10.1248/cpb.35.380010.1248/cpb.35.3800 ↗
82. Takeuchi H., Kojima H., Toyoda T., Yamamoto H., Hino T., Kawashima Y., Prolonged circulation time of doxorubicin-loaded liposomes coated with a modified polyvinyl alcohol after intravenous injection in rats, European Journal of Pharmaceutics and Biopharmaceutics, 48 (1999a) 123–129. DOI: 10.1016/S0939-6411(99)00029-610.1016/S0939-6411(99)00029-6 ↗
83. Takeuchi H., Kojima H., Yamamoto H., Kawashima Y., Enhanced tumour accumulation of doxorubicin with polymer-coated liposomes in rats, Pharmacy and Pharmacology Communications, 5 (1999b) 445–448. DOI: 10.1211/14608089912873514410.1211/146080899128735144 ↗
84. Takeuchi H., Kojima H., Yamamoto H., Kawashima Y., Polymer coating of liposomes with a modified polyvinyl alcohol and their systemic circulation and RES uptake in rats, Journal of Controlled Release, 68 (2000a) 195–205. DOI: 10.1016/S0168-3659(00)00260-110.1016/S0168-3659(00)00260-1 ↗
85. Takeuchi H., Kojima H., Yamamoto H., Kawashima Y., Evaluation of circulation profiles of liposomes coated with hydrophilic polymers having different molecular weights in rats, Journal of Controlled Release: official journal of the Controlled Release Society, 75 (2001a) 83–91. DOI: 10.1016/s0168-3659(01)00368-610.1016/S0168-3659(01)00368-6 ↗
86. Takeuchi H., Kojima H., Yamamoto H., Kawashima Y., Evaluation of the anti-tumour activity of liposomal doxorubicin coated with hydrophilic polymers in tumour-bearing mice, STP pharma sciences, 11 (2001b) 271–274.
87. Takeuchi H., Kojima H., Yamamoto H., Kawashima Y., Passive targeting of doxorubicin with polymer coated liposomes in tumor bearing rats, Biological and Pharmaceutical Bulletin, 24 (2001c) 795–799. DOI: 10.1248/bpb.24.79510.1248/bpb.24.795 ↗
88. Takeuchi H., Matsui Y., Sugihara H., Yamamoto H., Kawashima Y., Effectiveness of submicron-sized, chitosan–coated liposomes in oral administration of peptide drugs, International Journal of Pharmaceutics, 303 (2005a) 160–170. DOI: 10.1016/j.ijpharm.2005.06.02810.1016/j.ijpharm.2005.06.028 ↗
89. Takeuchi H., Matsui Y., Yamamoto H., Kawashima Y., Mucoadhesive properties of carbopol or chitosan-coated liposomes and their effectiveness in the oral administration of calcitonin to rats, Journal of Controlled Release, 86 (2003a) 235–242. DOI: 10.1016/S0168-3659(02)00411-X10.1016/S0168-3659(02)00411-X ↗
90. Takeuchi H., Nagira S., Aikawa M., Yamamoto H., Kawashima Y., Effect of lubrication on the compaction properties of pharmaceutical excipients as measured by die wall pressure, Journal of Drug Delivery Science and Technology, 15 (2005b) 177–182. DOI: 10.1016/S1773-2247(05)50023-610.1016/S1773-2247(05)50023-6 ↗
91. Takeuchi H., Nagira S., Yamamoto H., Kawashima Y., Design of solid dispersion particles of drug with fine porous carriers, Journal of the Society of Powder Technology, Japan, 40 (2003b) 157–162. DOI: 10.4164/sptj.40.15710.4164/sptj.40.157 ↗
92. Takeuchi H., Nagira S., Yamamoto H., Kawashima Y., Solid dispersion particles of tolbutamide prepared with fine silica particles by the spray-drying method, Powder Technology, 141 (2004a) 187–195. DOI: 10.1016/j.powtec.2004.03.00710.1016/j.powtec.2004.03.007 ↗
93. Takeuchi H., Nagira S., Yamamoto H., Kawashima Y., Die wall pressure measurement for evaluation of compaction property of pharmaceutical materials, International Journal of Pharmaceutics, 274 (2004b) 131–138. DOI: 10.1016/j.ijpharm.2004.01.00810.1016/j.ijpharm.2004.01.008 ↗
94. Takeuchi H., Onodera R., Preparation of nano particles from a liquid phase and dosage form design, Funtai-Gijutsu, 7(6) (2015) 537–541.
95. Takeuchi H., Sasaki H., Niwa T., Hino T., Kawashima Y., Uesugi K., Kayano M., Miyake Y., Preparation of powdered redispersible vitamin e acetate emulsion by spray-drying technique, Chemical & Pharmaceutical Bulletin, 39 (1991) 1528–1531. DOI: 10.1248/cpb.39.152810.1248/cpb.39.1528 ↗
96. Takeuchi H., Thongborisute J., Matsui Y., Sugihara H., Yamamoto H., Kawashima Y., Novel mucoadhesion tests for polymers and polymer-coated particles to design optimal mucoadhesive drug delivery systems, Advanced Drug Delivery Reviews, 57 (2005c) 1583–1594. DOI: 10.1016/j.addr.2005.07.00810.1016/j.addr.2005.07.008 ↗
97. Takeuchi H., Yamakawa R., Nishimatsu T., Takeuchi Y., Hayakawa K., Maruyama N., Design of rapidly disintegrating drug delivery films for oral doses with hydroxypropyl methylcellulose, Journal of Drug Delivery Science and Technology, 23 (2013) 471–475. DOI: 10.1016/S1773-2247(13)50068-210.1016/S1773-2247(13)50068-2 ↗
98. Takeuchi H., Yamamoto H., Kawashima Y., Mucoadhesive nanoparticulate systems for peptide drug delivery, Advanced Drug Delivery Reviews, 47 (2001d) 39–54. DOI: 10.1016/S0169-409X(00)00120-410.1016/S0169-409X(00)00120-4 ↗
99. Takeuchi H., Yamamoto H., Niwa T., Hino T., Kawashima Y., Mucoadhesion of polymer-coated liposomes to rat intestine in vitro, Chemical & Pharmaceutical Bulletin, 42 (1994) 1954–1956. DOI: 10.1248/cpb.42.195410.1248/cpb.42.1954 ↗
100. Takeuchi H., Yamamoto H., Niwa T., Hino T., Kawashima Y., Enteral absorption of insulin in rats from mucoadhesive chitosan-coated liposomes, Pharmaceutical Research, 13 (1996) 896–901. DOI: 10.1023/A:101600931354810.1023/A:1016009313548 ↗